Cerenome (CNSY) Total Current Liabilities (2010 - 2026)
Powered by 
Analysis
Cerenome (CNSY) Total Current Liabilities (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | 1.58 Bn |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | 2.53 Bn |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | 354.06 Mn |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | 2.12 Bn |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | 1.51 Bn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 630.93 Mn |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 438.74 Mn |
| 10 | Cerenome | 20.42 Mn | 11.83 Mn | - | 8.57 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.57 Mn |
| Mar 31, 2026 | 7.96 Mn |
| Dec 31, 2025 | 12.31 Mn |
| Sep 30, 2025 | 13.62 Mn |
| Jun 30, 2025 | 7.32 Mn |
| Mar 31, 2025 | 10.56 Mn |
| Dec 31, 2024 | 15.55 Mn |
| Sep 30, 2024 | 12.11 Mn |
| Jun 30, 2024 | 18.79 Mn |
| Mar 31, 2024 | 10.40 Mn |
| Dec 31, 2023 | 10.73 Mn |
| Sep 30, 2023 | 10.54 Mn |
| Jun 30, 2023 | 11.40 Mn |
| Mar 31, 2023 | 12.80 Mn |
| Dec 31, 2022 | 11.85 Mn |
| Sep 30, 2022 | 7.42 Mn |
| Jun 30, 2022 | 6.97 Mn |
| Mar 31, 2022 | 4.92 Mn |
| Dec 31, 2021 | 5.87 Mn |
| Sep 30, 2021 | 9.49 Mn |